marketcap
Facebook
Twitter
Telegram
Report an ErrorIntersect ENT, Inc. Financial Statements 2011-2024 | XENT
Annual Financial Statements Intersect ENT, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
735 M | 831 M | 882 M | 1.08 B | 369 M | 466 M | 240 M | - | - | - |
Shares |
32.7 M | 31.4 M | 30.3 M | 29.1 M | 28.4 M | 26.2 M | 11.4 M | - | - | - |
Net Income |
-72.3 M | -43 M | -22.9 M | -16.4 M | -25.2 M | -26.6 M | -18.4 M | -18.4 M | -16.4 M | - |
Revenue |
80.6 M | 109 M | 108 M | 96.3 M | 78.7 M | 61.6 M | 38.6 M | 17.9 M | 5.86 M | - |
EBITDA |
-64.8 M | -41.5 M | -23.1 M | -16.1 M | -24.9 M | -26.1 M | -17.5 M | -17.5 M | -16.1 M | - |
Operating Expenses |
118 M | 133 M | 111 M | 98.4 M | 91.8 M | 76.2 M | 46.4 M | 27.7 M | 18.5 M | - |
General and Administrative Expenses |
98.6 M | 108 M | 91.6 M | 80 M | 72.9 M | 59.6 M | 36.1 M | - | - | - |
All numbers in USD currency